Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
{{output}}
A severe and progressive interstitial lung disease (ILD) known as idiopathic pulmonary fibrosis (IPF) has an unknown etiology with poorly defined mechanisms of development. Among the currently prescribed pharmacological interventions for IPF, nintedanib demons... ...
